QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
NYSE:RMED

Ra Medical Systems - RMED Stock Forecast, Price & News

$3.06
+0.04 (+1.32%)
(As of 02/2/2023 01:18 PM ET)
Add
Compare
Today's Range
$2.97
$3.12
50-Day Range
$2.11
$6.78
52-Week Range
$2.03
$42.00
Volume
99,546 shs
Average Volume
327,636 shs
Market Capitalization
$3.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

RMED stock logo

About Ra Medical Systems (NYSE:RMED) Stock

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.

Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Stock News Headlines

Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
Ra Medical Systems
Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
Why Was Ra Medical Systems (RMED) Stock Up 20% Today?
5 Penny Stocks to Sell Before They Hit Zero
See More Headlines
Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Company Calendar

Last Earnings
11/14/2022
Today
2/02/2023
Next Earnings (Estimated)
3/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
58
Year Founded
N/A

Profitability

Net Income
$-25,070,000.00
Net Margins
-110,533.34%
Pretax Margin
-142,047.39%

Debt

Sales & Book Value

Annual Sales
$20,000.00
Book Value
$97.53 per share

Miscellaneous

Free Float
1,085,000
Market Cap
$3.34 million
Optionable
Not Optionable
Beta
0.05

Key Executives

  • Jonathan Will McGuireJonathan Will McGuire
    Chief Executive Officer & Director
  • Brian D. Conn
    Chief Financial & Accounting Officer
  • Alvin Memmolo
    VP-Clinical, Quality & Regulatory Affairs
  • Christopher Folk
    Vice President-Engineering
  • Maria Villanueva Sessions
    Vice President & Compliance Officer













RMED Stock - Frequently Asked Questions

Should I buy or sell Ra Medical Systems stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ra Medical Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMED shares.
View RMED analyst ratings
or view top-rated stocks.

How have RMED shares performed in 2023?

Ra Medical Systems' stock was trading at $5.89 at the beginning of the year. Since then, RMED shares have decreased by 48.7% and is now trading at $3.02.
View the best growth stocks for 2023 here
.

When is Ra Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our RMED earnings forecast
.

How were Ra Medical Systems' earnings last quarter?

Ra Medical Systems, Inc (NYSE:RMED) released its quarterly earnings data on Monday, November, 14th. The company reported ($3.86) earnings per share for the quarter. Ra Medical Systems had a negative trailing twelve-month return on equity of 169.55% and a negative net margin of 110,533.34%.

When did Ra Medical Systems' stock split?

Ra Medical Systems shares reverse split on Monday, October 3rd 2022. The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Ra Medical Systems own?
When did Ra Medical Systems IPO?

(RMED) raised $50 million in an initial public offering on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is Ra Medical Systems' stock symbol?

Ra Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

How do I buy shares of Ra Medical Systems?

Shares of RMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ra Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $3.02.

How much money does Ra Medical Systems make?

Ra Medical Systems (NYSE:RMED) has a market capitalization of $3.29 million and generates $20,000.00 in revenue each year. The company earns $-25,070,000.00 in net income (profit) each year or ($92.36) on an earnings per share basis.

How can I contact Ra Medical Systems?

Ra Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The official website for the company is www.ramed.com. The company can be reached via phone at (442) 245-4195 or via email at jcain@lhai.com.

This page (NYSE:RMED) was last updated on 2/2/2023 by MarketBeat.com Staff